Suggestions
Valerie Greger
Director of Research at The Yaya Foundation For 4H Leukodystrophy
Valerie Greger is an accomplished scientist and leader in the field of human genetics and genomics, bringing extensive experience in molecular biology to her varied roles within the scientific community. With a career that showcases a profound commitment to advancing clinical diagnostics and personalized medicine, she has dedicated her professional life to transforming scientific discoveries into practical applications that improve health outcomes. Valerie's strategic mindset combined with her analytical skills has allowed her to effectively navigate global environments while collaborating with multidisciplinary teams, particularly in dynamic start-up settings that require agility and innovation.
Valerie's professional journey is decorated with substantive roles that have shaped her expertise in a range of areas including medical genetics, genome interpretation, and data analysis. As the current Research Director at the National Tay-Sachs & Allied Diseases Association, she is at the forefront of research initiatives aimed at understanding and combating rare genetic disorders. Prior to this role, she made significant contributions as the Research Director at The Yaya Foundation For 4H Leukodystrophy, where she focused on genetic research to benefit affected individuals and families.
Before taking on these leadership positions, Valerie honed her skills in various capacities, including her tenure as Senior Program Manager at Seven Bridges, where she managed important genomic data projects. She also served as the Director of Genetic Research at Good Start Genetics, Inc., leading groundbreaking work in carrier screening and variant evaluation. Throughout her career, she has been recognized for her ability to design and execute strategic plans that align with organizational goals, ensuring successful project outcomes and scientific advancements.
A recognized thought leader in her field, Valerie has also played key roles in several organizations including serving as a Senior Scientist at both Interleukin Genetics and Millennium Pharmaceuticals, Inc., where she led significant projects such as the Human Genetics of Asthma Study. Having co-founded Zeetix, LLC, her entrepreneurial spirit has driven her to seek out and develop innovative solutions in genomics. Additionally, her academic contributions as an Adjunct Faculty member at Brandeis University demonstrate her dedication to education and mentorship in the next generation of scientists.
Valerie’s expertise extends to a variety of specialized areas, particularly focusing on rare diseases and the genetic disorders prevalent in Ashkenazi Jewish populations, as well as hearing loss. Her work in data curation and genome interpretation further highlights her dedication to precision medicine, where she strives to create tailored healthcare solutions that account for individual genetic profiles. She actively engages with the scientific community to promote the importance of genomic medicine in the contemporary healthcare landscape.
